New York, New York-- (Newsfile Corp. - March 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, ...

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They discuss: How ...

Novo Nordisk (NYSE:NVO) is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced price of $499 per month for certain cash-paying patients.

Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...

Shares of Hims and Hers (NYSE: HIMS) fell 3% amidst news of Novo Nordisk (NYSE: NVO) introducing NovoCare Pharmacy, which directly impacts the competitive landsca ...

As a measles outbreak in West Texas continues to grow, the response from US Health and Human Services Secretary Robert F.

Bernstein analysts told investors in a note Tuesday that Eli Lilly (NYSE: LLY) is gaining ground in the GLP-1 market, edging ...

FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds. See why I rate the fund a buy.

Surgical Sphincteroplasty Market. The global surgical sphincteroplasty market is on a trajectory of significant growth, projected to expand from USD 1.8 billion in 2024 to an esti ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore -based Hummingbird ...

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...